ArkeaBio appointed Dr. Zach Serber as CTO to accelerate its methane-reducing cattle vaccine toward 2026 field trials. Serber, who scaled Zymergen from startup to IPO, joins as the company targets commercial deployment by 2030. Meanwhile, Time2Graze launches satellite-guided grazing optimization across eight countries, while Mars backs fourteen ventures including four methane-reduction startups, signaling massive investment momentum in livestock climate solutions that promise immediate farm-level benefits.
ArkeaBio appointed Dr. Zach Serber as CTO to accelerate its methane-reducing cattle vaccine toward 2026 field trials. Serber, who scaled Zymergen from startup to IPO, joins as the company targets commercial deployment by 2030. Meanwhile, Time2Graze launches satellite-guided grazing optimization across eight countries, while Mars backs fourteen ventures including four methane-reduction startups, signaling massive investment momentum in livestock climate solutions that promise immediate farm-level benefits.